ID   HeLa-LTR-lacZ clone Z24
AC   CVCL_E8AP
SY   HeLa LTR-lacZ clone Z24; Z24
RX   PubMed=1560526;
RX   PubMed=7520946;
CC   Population: African American.
CC   Characteristics: Transfected with a construct pMA175 containing the HIV-1 BRU LTR that allows expression of lacZ when Tat is present (PubMed=1560526).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
RX   PubMed=1560526; DOI=10.1128/JVI.66.5.2814-2820.1992; PMCID=PMC241038;
RA   Charneau P., Alizon M., Clavel F.;
RT   "A second origin of DNA plus-strand synthesis is required for optimal
RT   human immunodeficiency virus replication.";
RL   J. Virol. 66:2814-2820(1992).
//
RX   PubMed=7520946; DOI=10.1006/jmbi.1994.1542;
RA   Charneau P., Mirambeau G., Roux P., Paulous S., Buc H., Clavel F.;
RT   "HIV-1 reverse transcription. A termination step at the center of the
RT   genome.";
RL   J. Mol. Biol. 241:651-662(1994).
//